Unique ID issued by UMIN | UMIN000043068 |
---|---|
Receipt number | R000049157 |
Scientific Title | Effect of insulin glargine and lixisenatide and insulin degludec and liraglutide on glucose variability and oxidative stress in type 2 diabetes patients |
Date of disclosure of the study information | 2021/01/20 |
Last modified on | 2021/01/20 21:37:06 |
Effect of insulin glargine and lixisenatide and insulin degludec and liraglutide on glucose variability and oxidative stress in type 2 diabetes patients
Effect of insulin glargine and lixisenatide and insulin degludec and liraglutide on glucose variability and oxidative stress in type 2 diabetes patients
Effect of insulin glargine and lixisenatide and insulin degludec and liraglutide on glucose variability and oxidative stress in type 2 diabetes patients
Effect of insulin glargine and lixisenatide and insulin degludec and liraglutide on glucose variability and oxidative stress in type 2 diabetes patients
Japan |
Type 2 diabetes mellitus
Endocrinology and Metabolism |
Others
NO
We aimed to investigate the effects of insulin glargine and lixisenatide and insulin degludec and liraglutide on oxidative stress and glucose variability before and 24 weeks after the start of the study.
Efficacy
oxidative stress and glucose variability
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine |
insulin degludec and liraglutide
insulin glargine and lixisenatide
20 | years-old | <= |
Not applicable |
Male and Female
1)a diagnosis of type 2 diabetes mellitus
2)20 years and over
3)HbA1c 7.0% or more
4)treatment with iusulin glargine and lixisenatide for 12weeks or longer
1)the use of steroids or anti-inflammatory drugs,
2)diabetic ketosis and coma within 3 months before the study,
3)severe infection, severe trauma, pre-and post-operation,
4)an estimated glomerular filtration rate are within 30mL/min/1.73m2,
5)malignancy,
6)pregnancy
7)Patients who are judged as inappropriate for inclusion by phsicians
30
1st name | Makoto |
Middle name | |
Last name | Ohara |
Showa University School of Medicine
Division of Diabetes and Endocrinology, Department of Internal Medicine
142-8666
1-5-8 Hatanodai, Shinagawa-ku, Tokyo
03-3784-8000
s6018@nms.ac.jp
1st name | Makoto |
Middle name | |
Last name | Ohara |
Showa University School of Medicine
Division of Diabetes and Endocrinology, Department of Internal Medicine
142-8666
1-5-8 Hatanodai, Shinagawa-ku, Tokyo
03-3784-8000
s6018@nms.ac.jp
Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine
Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine
Self funding
Ethics comittee specializing in human subgects reserch at the Showa University
1-5-8 Hatanodai, Shinagawa-ku, Tokyo
03-3784-8129
gakuji@ofc.showa-u.ac.jp
NO
2021 | Year | 01 | Month | 20 | Day |
Unpublished
Open public recruiting
2020 | Year | 12 | Month | 03 | Day |
2021 | Year | 01 | Month | 19 | Day |
2021 | Year | 01 | Month | 20 | Day |
2022 | Year | 12 | Month | 31 | Day |
2021 | Year | 01 | Month | 20 | Day |
2021 | Year | 01 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049157
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |